![Evelo Biosciences, Inc. logo](/logos/EVLO.webp)
Evelo Biosciences, Inc.
NASDAQ:EVLO
Overview | Financials
Company Name | Evelo Biosciences, Inc. |
Symbol | EVLO |
Currency | USD |
Price | 0 |
Market Cap | 1,898 |
Dividend Yield | 0% |
52-week-range | 0 - 7.32 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Dr. Balkrishan Gill Ph.D. |
Website | https://www.evelobio.com |
An error occurred while fetching data.
About Evelo Biosciences, Inc.
Evelo Biosciences, Inc., a biotechnology company, discovers and develops oral biologics for the treatment of inflammatory diseases and cancer. It is developing EDP1815, a whole-microbe candidate for the treatment of inflammatory diseases; and is in Phase 2 clinical trial for the treatment of psoriasis and atopic dermatitis, as well as
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD